Form 4: Becton Dickinson Executive Roland Goette Sells Shares
SEC Filing
EVP and President EMEA of Becton Dickinson, Roland Goette, sold shares of common stock on May 15, 2024, according to a Form 4 filing with the SEC.
Summary
- Roland Goette, an Executive Vice President and President EMEA at Becton Dickinson & Co, reported the sale of company common stock on May 15, 2024.
- The sales were executed in multiple transactions at weighted average prices of $235.29, $236.99, and $237.46.
- Goette sold 800 shares at an average price of $235.29, 1,400 shares at an average price of $236.99, and 1,100 shares at an average price of $237.46.
- Following the reported transactions, Goette directly owns 11,308 shares of Becton Dickinson common stock.
- He also indirectly owns 1,185 shares through the Becton, Dickinson and Company Global Share Investment Program (GSIP).
- The information regarding the GSIP holdings is presented as of May 15, 2024.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock sales by an executive, which is neither inherently positive nor negative. The sentiment is neutral.
Industry Context
Executive stock sales are a common occurrence and are often scrutinized by investors for insights into a company's prospects. It's important to consider the context of these sales, such as the executive's overall holdings and any pre-arranged trading plans.
Comparison to Industry Standards
- Executive compensation and stock ownership are common across publicly traded companies like Becton Dickinson.
- Comparing Goette's transactions to those of executives at similar medical technology companies (e.g., Medtronic, Johnson & Johnson) could provide a benchmark for assessing the significance of these sales.
- Reviewing the frequency and size of executive stock transactions at these comparable companies can offer insights into industry norms.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, potentially causing a slight decrease in stock price due to increased supply.
- The impact on employees, customers, suppliers, and creditors is expected to be negligible.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | Date of stock sale transactions. |
| 05/16/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.